U.S. equities bogged down by sluggish earnings

"Pockets of value" remain, says Beutel Goodman's Glenn Fortin.

Sonita Horvitch 24 June, 2015 | 5:00PM

Glenn Fortin, global equity analyst and portfolio manager at Beutel Goodman & Co. Ltd., says that the U.S. equity market has been a lacklustre performer so far this year, with the consensus that U.S. larger-cap corporate earnings per share will show little or no growth in 2015.

"The benchmark S&P 500 Index is essentially flat since the beginning of this year in U.S.-dollar terms," says Fortin. But interestingly, he says, the NASDAQ Index, which has heavy weightings in both the technology and the health-care sectors, has done modestly better, though its return is still in the single-digit range in U.S.-dollar terms. "These two key U.S. sectors have been strong performers so far this year."

A specialist in U.S. stocks and a value manager, Fortin notes that financial analysts have been downgrading their earnings estimates for 2015, reflecting in part the adverse impact of the strong U.S. dollar on U.S. companies with a global reach. "A large number of large-cap and mid-cap U.S. companies have significant international operations and the strong U.S. dollar is a headwind," he says.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar Rating
Amdocs Ltd68.07 USD-1.13
Baxter International Inc87.03 USD0.05
Eli Lilly and Co133.53 USD-1.39
Johnson & Johnson143.68 USD-0.67
Kellogg Co62.77 USD-0.98
Merck & Co Inc79.94 USD-0.41
Oracle Corp52.05 USD2.14
Parker Hannifin Corp189.67 USD-2.47
Symantec Corp19.30 USD0.89
Teradyne Inc61.43 USD-0.32

About Author

Sonita Horvitch

Sonita Horvitch